Vivek Jain - Dec 28, 2021 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Chairman and CEO, Director
Signature
By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain
Stock symbol
ICUI
Transactions as of
Dec 28, 2021
Transactions value $
-$2,174,533
Form type
4
Date filed
12/30/2021, 03:59 PM
Previous filing
Nov 5, 2021
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $9.64K +164 +1.28% $58.79 12.9K Dec 28, 2021 Direct F1
transaction ICUI Common Stock Sale -$39.4K -164 -1.27% $240.00 12.8K Dec 28, 2021 Direct F1, F2
transaction ICUI Common Stock Options Exercise $628K +10.7K +83.55% $58.79 23.5K Dec 29, 2021 Direct F1
transaction ICUI Common Stock Sale -$2.56M -10.7K -45.52% $240.00 12.8K Dec 29, 2021 Direct F1, F3
transaction ICUI Common Stock Options Exercise $68.1K +1.16K +9.07% $58.79 13.9K Dec 30, 2021 Direct F1
transaction ICUI Common Stock Sale -$278K -1.16K -8.32% $240.00 12.8K Dec 30, 2021 Direct F1, F2
holding ICUI Common Stock 60K Dec 28, 2021 by Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -164 -0.06% $0.00 254K Dec 28, 2021 Common Stock 164 $58.79 Direct F1
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -10.7K -4.2% $0.00 244K Dec 29, 2021 Common Stock 10.7K $58.79 Direct F1
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.16K -0.48% $0.00 242K Dec 30, 2021 Common Stock 1.16K $58.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021.
F2 All shares sold were sold at the exact price disclosed.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.00 to $240.07, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.